Clinical Trials
50 trials registered for Hemophilia A
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
NCT04431726Phase 3Hoffmann-La Roche
Active↗
Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults
NCT04370054Phase 3Pfizer
Active↗
Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding
NCT04461639N/ABayer
Active↗
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
NCT03528551Phase 3Novo Nordisk A/S
Completed↗
A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People
NCT05127473Phase 1Novo Nordisk A/S
Completed↗
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)
NCT03587116Phase 3Pfizer
Completed↗
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
NCT02622321Phase 3Hoffmann-La Roche
Completed↗
A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France
NCT03655340N/ASwedish Orphan Biovitrum
Completed↗
A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A
NCT01233258Phase 3Bayer
Completed↗
An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B
NCT03901755N/ASwedish Orphan Biovitrum
Completed↗
An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.
NCT02250482Phase 3Bio Products Laboratory
Completed↗
BAX 326 (rFIX) Continuation Study
NCT01286779Phase 3Baxalta now part of Shire
Completed↗
Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects
NCT01561417Phase 1Novo Nordisk A/S
Completed↗
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
NCT01392547Phase 3Novo Nordisk A/S
Completed↗
Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A
NCT02938585Phase 3Novo Nordisk A/S
Completed↗
Factor Product Utilization and Health Outcomes in Patients With Hemophilia
NCT02796222N/AUniversity of British Columbia
Completed↗
Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia
NCT03185897N/ABaxalta now part of Shire
Completed↗
Hemophilia Inhibitor Genetics Study (HIGS)
NCT00166387N/ASkane University Hospital
Completed↗
Imaging of Arthropathy in Boys With Hemophilia in China
NCT03914716N/AAndrea Doria
Completed↗
Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects
NCT01272206Phase 1Novo Nordisk A/S
Completed↗